On 2/29/24, Catalyst Pharmaceutical Inc (NASDAQ: CPRX) stock enjoyed a major increase of 10.1%, closing at $16.03. Moreover, trading volume in this advance was exceptionally high at 282% of normal. The stock has risen 16.9% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, CPRX is expected to continue to be a major Value Builder.
Catalyst Pharmaceutical has a current Value Trend Rating of A (Highest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Catalyst Pharmaceutical has a good Power Rating of 71 and a very high Appreciation Score of 97, and the Highest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment